Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and pathological features of oncocytic adrenocortical carcinoma: a retrospective comparative study.

Journal of endocrinological investigation·2026
Same author

DeepEN: A deep reinforcement learning framework for personalized enteral nutrition in critical care.

Journal of biomedical informatics·2026
Same author

Analysis of clinical and pathological characteristics of classic adrenocortical carcinoma.

Scientific reports·2026
Same author

Avian coronaviruses induce inflammatory responses by activating p38/MAPK signaling and NLRP3/caspase-1 inflammasomes through sphingosine-1-phosphate receptor 1.

Veterinary research·2026
Same author

GSK3β functions as a mechanosensitive regulator that links flow stress to Shh signaling.

Experimental cell research·2026
Same author

Contactless gas-sensitive photoelectrochemical biosensor for determination of Salmonella typhimurium based on SnO<sub>2</sub>/CeO<sub>2</sub> heterojunction.

Analytica chimica acta·2026

Related Experiment Video

Updated: Jan 7, 2026

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
06:42

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution

Published on: May 9, 2025

1.0K

A Single-Component Nanotheranostic Platform for Synchronous Cancer Imaging, Phototherapy, and Immune Activation.

Jiayang Chen1, Liang Mo1

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of University of South China, Hengyang, China.

Luminescence : the Journal of Biological and Chemical Luminescence
|December 28, 2025
PubMed
Summary

A novel nanotheranostic platform using IDIC-Phc6 nanoparticles offers combined tumor imaging, hyperthermia, and photodynamic therapy. This approach effectively inhibits tumor growth and remodels the immune microenvironment for potential clinical translation.

Keywords:
Photothermal therapyimmune activationimmunogenic cell deathphotodynamic therapy

More Related Videos

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.3K
Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
05:39

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

3.7K

Related Experiment Videos

Last Updated: Jan 7, 2026

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
06:42

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution

Published on: May 9, 2025

1.0K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.3K
Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
05:39

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

3.7K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Developing integrated nanomedicine platforms for simultaneous diagnosis and therapy is crucial for effective cancer treatment.
  • Overcoming tumor hypoxia and immune suppression remains a significant challenge in phototherapy.

Purpose of the Study:

  • To create a single-component nanotheranostic platform for enhanced tumor imaging and synergistic phototherapy.
  • To investigate the platform's ability to overcome tumor hypoxia and activate anti-tumor immunity.

Main Methods:

  • Assembly of IDIC-Phc6 photosensitizer with DSPE-PEG-NH₂ to form nanoparticles (NPs).
  • Evaluation of NP performance in vitro and in vivo, including imaging, photothermal, and photodynamic therapy efficacy.
  • Assessment of cellular responses, including apoptosis and immunogenic cell death (ICD), and immune microenvironment modulation.

Main Results:

  • IDIC-Phc6 NPs exhibited high photothermal conversion efficiency (43.5%) and singlet oxygen generation (ΦΔ = 48.7%).
  • In vitro studies showed NP biocompatibility and laser-induced tumor cell apoptosis and ICD.
  • In vivo experiments demonstrated precise tumor imaging, significant tumor growth inhibition, and immune microenvironment remodeling.

Conclusions:

  • The single-component IDIC-Phc6 nanotheranostic platform integrates theranostics and synergistic therapy for effective cancer treatment.
  • This platform overcomes tumor microenvironment barriers, offering a promising solution for precision phototherapy and clinical translation.